Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. Nagarro SE
  6. News
  7. Summary
    NA9   DE000A3H2200

NAGARRO SE

(NA9)
  Report
Delayed Quote. Delayed Deutsche Boerse AG - 01/21 11:27:15 am
158 EUR   -1.25%
01/21NAGARRO SE : Nagarro joins forces with Techmill Global
EQ
01/14NAGARRO : Jefferies reiterates its Neutral rating
MD
01/14NAGARRO SE : Guidance FY 2022
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Nagarro partners with BioT to deliver best-in-class software for medical devices

11/24/2021 | 04:43am EST

DUBAI, UAE, Nov. 24, 2021 /CNW/ -- Nagarro, a global digital engineering company, and BioT Medical, a No-code connected-care platform for medical devices, announced a strategic partnership. In an age of data-driven hyper-personalized care, maximizing the medical device potential has never been more critical. The Nagarro BioT partnership represents the best of two worlds, digital engineering excellence, and connected medical device mastery.

This partnership will allow device manufacturers to transform any medical device into a connected care platform within days and build an end-to-end personalized patient care system that is purposefully built for their needs and is fully integrated with the existing caregiver's ecosystem and workflows. Device manufacturers can now benefit from a direct-to-consumer relationship while providing caregivers with better care capabilities using their existing workflows. 

"Our partnership with Nagarro will help fuel both companies' continued innovation and growth efforts. Through our regulated connected care, no-code platform, BioT will enable Nagarro to easily and quickly expand their best-in-class digital health offerings to the broader healthcare market. Together we can deliver a new level of value for medical device manufacturers, their patients, and the entire healthcare ecosystem," says Daniel Adler, Co-Founder & CEO at BioT Medical

"Digital health ecosystems evolve every day, so do connected medical devices and Software as a Medical Device. The future will be for those who understand the value of connected data integrated into their SaaS solutions and creating personalized care experiences. We are very excited by what BioT is doing in the Life Sciences space. Together we represent that vision. We have a long history of developing Life Sciences solutions around the world and look forward to bringing even more complete and integrated solutions with this exciting partnership," added Andrei Doibani, Global Business Unit Head for Life Sciences and Healthcare at Nagarro. 

About BioT 

BioT is a medical-grade PaaS (Platform-as-a-service) that, for the first time, introduces a no-code approach to the regulated medical device space. It's a game-changing solution to get medical devices on the cloud in a snap using a template-based drag-and-drop approach, without losing precious time or investing huge development efforts and costs. BioT's Triple-C Connect-Collaborate-Care solution enables medical device manufacturers to securely connect devices to a medical-grade cloud, boost personalized engagement and improve health outcomes through collaboration between patients and caregivers, and turn data into actionable insights to improve clinical decision-making and care experiences. For more information, visit www.biot-med.com.  

About Nagarro 

Nagarro, a global digital engineering leader, helps clients become innovative, digital-first companies and thus, win in their markets. The company is distinguished by its entrepreneurial, agile, and global character, its CARING mindset, and its approach of "Thinking Breakthroughs". Nagarro employs over 10,000 people in 26 countries. For more information, visit www.nagarro.com.  

FRA: NA9 (SDAX, ISIN DE000A3H2200, WKN A3H220) 

For inquiries, please contact press@nagarro.com 

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/nagarro-partners-with-biot-to-deliver-best-in-class-software-for-medical-devices-301431469.html

SOURCE Nagarro

© Canada Newswire, source Canada Newswire English

All news about NAGARRO SE
01/21NAGARRO SE : Nagarro joins forces with Techmill Global
EQ
01/14NAGARRO : Jefferies reiterates its Neutral rating
MD
01/14NAGARRO SE : Guidance FY 2022
EQ
01/14Nagarro SE Provides Revenue Guidance For 2022
CI
2021NAGARRO SE(XTRA : NA9) added to Germany TECDAX Index (Price Return)
CI
2021NAGARRO SE(XTRA : NA9) added to Germany TECDAX (Total Return) Index
CI
2021NAGARRO SE : Raised guidance FY 2021
EQ
2021Nagarro SE Raises Earnings Guidance for the Fiscal Year 2021
CI
2021NAGARRO SE : Deutsche Börse includes Nagarro in TecDAX index
EQ
2021Nagarro partners with BioT to deliver best-in-class software for medical devices
AQ
More news
Analyst Recommendations on NAGARRO SE
More recommendations
Financials
Sales 2021 533 M 604 M 604 M
Net income 2021 22,7 M 25,7 M 25,7 M
Net Debt 2021 95,2 M 108 M 108 M
P/E ratio 2021 85,7x
Yield 2021 -
Capitalization 2 177 M 2 469 M 2 467 M
EV / Sales 2021 4,26x
EV / Sales 2022 3,14x
Nbr of Employees 12 052
Free-Float -
Chart NAGARRO SE
Duration : Period :
Nagarro SE Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 158,00 €
Average target price 197,33 €
Spread / Average Target 24,9%
EPS Revisions
Managers and Directors
Manas Chandra Fuloria Chairman-Management Board
Carl Georg DŘrschmidt Chairman-Supervisory Board
Vikram Sehgal Chief Operating Officer
Detlef Dinsel Vice Chairman-Supervisory Board
Shalini Sarin Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
NAGARRO SE-21.39%2 469
ACCENTURE PLC-19.04%212 118
TATA CONSULTANCY SERVICES LTD.2.55%190 800
INTERNATIONAL BUSINESS MACHINES CORPORATION-3.22%116 001
INFOSYS LIMITED-5.41%100 701
AUTOMATIC DATA PROCESSING, INC.-10.65%91 495